vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与UNITED STATES LIME & MINERALS INC（USLM）财务数据对比。点击上方公司名可切换其他公司
UNITED STATES LIME & MINERALS INC的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.2倍（$87.9M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 9.8%），UNITED STATES LIME & MINERALS INC自由现金流更多（$25.7M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 10.8%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
美国石灰矿产公司是总部位于美国的自然资源企业，主营高钙石灰、白云石石灰、石灰石及相关矿产制品，客户覆盖基建、钢铁制造、农业土壤改良、环保排放治理、工业加工等领域，业务主要辐射北美市场。
PBYI vs USLM — 直观对比
营收规模更大
USLM
是对方的1.2倍
$75.5M
营收增速更快
PBYI
高出17.9%
9.8%
自由现金流更多
USLM
多$11.3M
$14.4M
两年增速更快
PBYI
近两年复合增速
10.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $87.9M |
| 净利润 | — | $30.5M |
| 毛利率 | 69.3% | 48.0% |
| 营业利润率 | 22.7% | 41.0% |
| 净利率 | — | 34.7% |
| 营收同比 | 27.7% | 9.8% |
| 净利润同比 | — | 13.2% |
| 每股收益（稀释后） | $0.26 | $1.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIUSLM
| Q4 25 | $75.5M | $87.9M | ||
| Q3 25 | $54.5M | $102.0M | ||
| Q2 25 | $52.4M | $91.5M | ||
| Q1 25 | $46.0M | $91.3M | ||
| Q4 24 | $59.1M | $80.1M | ||
| Q3 24 | $80.5M | $89.4M | ||
| Q2 24 | $47.1M | $76.5M | ||
| Q1 24 | $43.8M | $71.7M |
净利润PBYIUSLM
| Q4 25 | — | $30.5M | ||
| Q3 25 | $8.8M | $38.8M | ||
| Q2 25 | $5.9M | $30.8M | ||
| Q1 25 | $3.0M | $34.1M | ||
| Q4 24 | — | $27.0M | ||
| Q3 24 | $20.3M | $33.4M | ||
| Q2 24 | $-4.5M | $26.1M | ||
| Q1 24 | $-4.8M | $22.4M |
毛利率PBYIUSLM
| Q4 25 | 69.3% | 48.0% | ||
| Q3 25 | 77.7% | 51.2% | ||
| Q2 25 | 76.5% | 45.8% | ||
| Q1 25 | 77.1% | 50.6% | ||
| Q4 24 | 76.4% | 44.3% | ||
| Q3 24 | 63.9% | 48.2% | ||
| Q2 24 | 77.4% | 45.5% | ||
| Q1 24 | 75.5% | 42.7% |
营业利润率PBYIUSLM
| Q4 25 | 22.7% | 41.0% | ||
| Q3 25 | 17.6% | 45.3% | ||
| Q2 25 | 12.7% | 39.0% | ||
| Q1 25 | 8.7% | 43.7% | ||
| Q4 24 | 22.6% | 38.8% | ||
| Q3 24 | 27.4% | 42.6% | ||
| Q2 24 | -4.6% | 39.1% | ||
| Q1 24 | -5.3% | 35.9% |
净利率PBYIUSLM
| Q4 25 | — | 34.7% | ||
| Q3 25 | 16.2% | 38.0% | ||
| Q2 25 | 11.2% | 33.7% | ||
| Q1 25 | 6.5% | 37.4% | ||
| Q4 24 | — | 33.7% | ||
| Q3 24 | 25.2% | 37.3% | ||
| Q2 24 | -9.6% | 34.0% | ||
| Q1 24 | -11.0% | 31.3% |
每股收益（稀释后）PBYIUSLM
| Q4 25 | $0.26 | $1.06 | ||
| Q3 25 | $0.17 | $1.35 | ||
| Q2 25 | $0.12 | $1.07 | ||
| Q1 25 | $0.06 | $1.19 | ||
| Q4 24 | $0.40 | $-2.20 | ||
| Q3 24 | $0.41 | $1.16 | ||
| Q2 24 | $-0.09 | $0.91 | ||
| Q1 24 | $-0.10 | $3.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $371.1M |
| 总债务越低越好 | $22.7M | $0 |
| 股东权益账面价值 | $130.3M | $630.8M |
| 总资产 | $216.3M | $681.0M |
| 负债/权益比越低杠杆越低 | 0.17× | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资PBYIUSLM
| Q4 25 | $97.5M | $371.1M | ||
| Q3 25 | $94.4M | $349.5M | ||
| Q2 25 | $96.0M | $319.9M | ||
| Q1 25 | $93.2M | $300.6M | ||
| Q4 24 | $101.0M | $278.0M | ||
| Q3 24 | $96.7M | $255.0M | ||
| Q2 24 | $96.8M | $222.5M | ||
| Q1 24 | $107.2M | $207.0M |
总债务PBYIUSLM
| Q4 25 | $22.7M | $0 | ||
| Q3 25 | $34.0M | $0 | ||
| Q2 25 | $45.3M | $0 | ||
| Q1 25 | $56.7M | $0 | ||
| Q4 24 | $68.0M | $0 | ||
| Q3 24 | $79.3M | $0 | ||
| Q2 24 | $90.7M | $0 | ||
| Q1 24 | $102.0M | $0 |
股东权益PBYIUSLM
| Q4 25 | $130.3M | $630.8M | ||
| Q3 25 | $115.3M | $602.3M | ||
| Q2 25 | $104.7M | $563.3M | ||
| Q1 25 | $97.1M | $532.2M | ||
| Q4 24 | $92.1M | $497.7M | ||
| Q3 24 | $71.1M | $474.2M | ||
| Q2 24 | $48.5M | $441.1M | ||
| Q1 24 | $51.0M | $415.3M |
总资产PBYIUSLM
| Q4 25 | $216.3M | $681.0M | ||
| Q3 25 | $202.9M | $652.8M | ||
| Q2 25 | $194.9M | $607.4M | ||
| Q1 25 | $196.2M | $585.3M | ||
| Q4 24 | $213.3M | $543.2M | ||
| Q3 24 | $220.7M | $521.8M | ||
| Q2 24 | $205.0M | $484.2M | ||
| Q1 24 | $214.1M | $464.0M |
负债/权益比PBYIUSLM
| Q4 25 | 0.17× | 0.00× | ||
| Q3 25 | 0.30× | 0.00× | ||
| Q2 25 | 0.43× | 0.00× | ||
| Q1 25 | 0.58× | 0.00× | ||
| Q4 24 | 0.74× | 0.00× | ||
| Q3 24 | 1.12× | 0.00× | ||
| Q2 24 | 1.87× | 0.00× | ||
| Q1 24 | 2.00× | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $45.6M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $25.7M |
| 自由现金流率自由现金流/营收 | 19.1% | 29.2% |
| 资本支出强度资本支出/营收 | 0.0% | 22.6% |
| 现金转化率经营现金流/净利润 | — | 1.49× |
| 过去12个月自由现金流最近4个季度 | $41.7M | $102.3M |
8季度趋势，按日历期对齐
经营现金流PBYIUSLM
| Q4 25 | $14.4M | $45.6M | ||
| Q3 25 | $9.7M | $45.9M | ||
| Q2 25 | $14.1M | $34.0M | ||
| Q1 25 | $3.6M | $39.4M | ||
| Q4 24 | $15.6M | $38.6M | ||
| Q3 24 | $11.0M | $39.0M | ||
| Q2 24 | $1.0M | $21.2M | ||
| Q1 24 | $11.2M | $27.2M |
自由现金流PBYIUSLM
| Q4 25 | $14.4M | $25.7M | ||
| Q3 25 | $9.7M | $31.3M | ||
| Q2 25 | $14.1M | $20.8M | ||
| Q1 25 | $3.6M | $24.6M | ||
| Q4 24 | $15.6M | $27.6M | ||
| Q3 24 | $11.0M | $33.9M | ||
| Q2 24 | $1.0M | $16.8M | ||
| Q1 24 | — | $20.3M |
自由现金流率PBYIUSLM
| Q4 25 | 19.1% | 29.2% | ||
| Q3 25 | 17.7% | 30.7% | ||
| Q2 25 | 26.8% | 22.7% | ||
| Q1 25 | 7.7% | 26.9% | ||
| Q4 24 | 26.4% | 34.4% | ||
| Q3 24 | 13.7% | 37.9% | ||
| Q2 24 | 2.1% | 21.9% | ||
| Q1 24 | — | 28.4% |
资本支出强度PBYIUSLM
| Q4 25 | 0.0% | 22.6% | ||
| Q3 25 | 0.0% | 14.4% | ||
| Q2 25 | 0.0% | 14.5% | ||
| Q1 25 | 0.1% | 16.3% | ||
| Q4 24 | 0.0% | 13.8% | ||
| Q3 24 | 0.0% | 5.8% | ||
| Q2 24 | 0.0% | 5.7% | ||
| Q1 24 | 0.0% | 9.5% |
现金转化率PBYIUSLM
| Q4 25 | — | 1.49× | ||
| Q3 25 | 1.10× | 1.18× | ||
| Q2 25 | 2.41× | 1.10× | ||
| Q1 25 | 1.21× | 1.16× | ||
| Q4 24 | — | 1.43× | ||
| Q3 24 | 0.54× | 1.17× | ||
| Q2 24 | — | 0.81× | ||
| Q1 24 | — | 1.21× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
